PJ
Plammoottil Janardhanan Pillai Abhilash
About Plammoottil Janardhanan Pillai Abhilash
Data last updated:
Plammoottil Janardhanan Pillai Abhilash is a Whole-Time Director at Incus Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Incus Pharmaceuticals Private Limited reported revenue of ₹6.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Incus Pharmaceuticals Private Limited U51397KL2009PTC024907 | Whole-Time Director | 08 Dec 2022 | 2009 | ₹6.38 Cr (FY 2025) | Active |
Board colleagues of Plammoottil Janardhanan Pillai Abhilash
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babu Philip | 02798186 | Incus Pharmaceuticals Private Limited | Whole-Time Director |
| Narayanan Priyaranjan Das | 02798203 | Incus Pharmaceuticals Private Limited | Managing Director |
| Thulaseedharan Pillai Suresh Kumar | 02798228 | Incus Pharmaceuticals Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Plammoottil Janardhanan Pillai Abhilash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Plammoottil Janardhanan Pillai Abhilash
Plammoottil Janardhanan Pillai Abhilash currently holds 1 directorship: Incus Pharmaceuticals Private Limited (Whole-Time Director, since 08 Dec 2022, revenue ₹6.38 Cr (FY 2025)).
Plammoottil Janardhanan Pillai Abhilash was first appointed on 08 Dec 2022 as Whole-Time Director at Incus Pharmaceuticals Private Limited.
The current boards of Plammoottil Janardhanan Pillai Abhilash's companies include Babu Philip (Incus Pharmaceuticals Private Limited), Narayanan Priyaranjan Das (Incus Pharmaceuticals Private Limited), Thulaseedharan Pillai Suresh Kumar (Incus Pharmaceuticals Private Limited).